• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Emphysema Companies

    ID: MRFR/Pharma/4354-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Emphysema companies focus on providing medical solutions for individuals with emphysema, a chronic lung condition characterized by the destruction of lung tissue. These companies contribute to pulmonology by offering medications, inhalers, and therapies to manage and improve respiratory function in individuals with emphysema.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Emphysema Market

    Emphysema Key CompaniesLatest Emphysema Companies Update

    AstraZeneca (Symbicort®) Partnered with healthcare providers to launch educational programs highlighting the benefits of long-acting bronchodilator/inhaled corticosteroid combination therapies for managing chronic symptoms and improving quality of life in emphysema patients.


    GlaxoSmithKline (Advair®) Focused on research and development of longer-acting versions of existing medications to potentially increase treatment adherence and improve outcomes for emphysema patients.


    Respironics (Philips Healthcare) Announced the expansion of their Trilogy® series of portable ventilators specifically designed for home-based pulmonary rehabilitation programs, improving accessibility for emphysema patients.


    Lung Foundation of America Received grants to pilot innovative virtual and hybrid pulmonary rehabilitation programs, aimed at increasing access and engagement for patients in remote areas or facing mobility limitations.


    Medtronic (Zephyr® Endobronchial Valve) Presented positive results from clinical trials on the effectiveness of their valve placement system in improving lung function and exercise capacity in emphysema patients.


    Spiration Therapeutics (AeriSeal® System) Focused on exploring potential applications of their lung volume reduction technology for treating early-stage emphysema and preventing disease progression.List of Emphysema Key Companies in the Market



    • Intrexon Corporation

    • Pulmonx Inc.

    • Halozyme Therapeutics, Inc.

    • Mariposa Health Limited

    • PneumRx

    • Uptake Medical Corporation

    • Icure Pharmaceuticals, Inc.

    • Pfizer, Inc.

    • BTG International’s

    • Olympus Corporation

    • Kamada Limited

    • Emphasys Medical, Inc.